Overview

Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

Status:
Suspended
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
This is a single center exploratory imaging study investigating the initial application of 89Zr-DFO-CZP PET in patients with rheumatoid arthritis. Patients with active symptoms of RA or signs on physical exam will be invited to participate for PET imaging.
Phase:
Phase 1
Details
Lead Sponsor:
Robert Flavell, MD, PhD
University of California, San Francisco
Treatments:
Certolizumab Pegol